Behavioral and Cellular Modulation of l-DOPA-Induced Dyskinesia by β-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat

Chronic dopamine replacement therapy in Parkinson's disease (PD) leads to deleterious motor sequelae known as l-DOPA-induced dyskinesia (LID). No known therapeutic can eliminate LID, but preliminary evidence suggests that dl-1-isopropylamino-3-(1-naphthyloxy)-2-propanol [(±)propranolol], a nons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lindenbach, David, Ostock, Corinne Y., Eskow Jaunarajs, Karen L., Dupre, Kristin B., Barnum, Christopher J., Bhide, Nirmal, Bishop, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Pharmacology and Experimental Therapeutics 2011
Assuntos:
Behavioral Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101009/
https://ncbi.nlm.nih.gov/pubmed/21402691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.111.179416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados